SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.
29 August 2021 (19:10 - 19:20)
Organised by:
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
2 More presentations in this session
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
29 August 2021
19:10 CET
You may be interested in
Congress Session
Congress Session
